| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d43c883aa035c2b0560e1968520554fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ada93d6301aaa41aea618d0b47a9ea7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56905
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-002 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-002 |
| filingDate |
1997-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08cec19e21f6224dc5fb58ed15491527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0aa32c817ad83b24a43f0deb0c75ff44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd545d048493c1df16160cd4d39d5b78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c32765c230ffa3519feefe831b010c5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1178c1cda182746d470521882c1480b |
| publicationDate |
1999-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0918868-A2 |
| titleOfInvention |
Antimicrobial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| abstract |
This invention relates to uses of components of plant-like metabolic pathways not including psbA or PPi phosphofructokinase and not generally operative in animals or encoded by the plastid DNA, to develop compositions that interfere with Apicomplexan growth and survival. Components of the pathways include enzymes, transit peptides and nucleotide sequences encoding the enzymes and peptides, or promoters of these nucleotide sequences to which antibodies, antisense molecules and other inhibitors are directed. Diagnostic and therapeutic reagents and vaccines are developed based on the components and their inhibitors. |
| priorityDate |
1996-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |